Fatty liver disease is a major untapped opportunity for nutraceuticals; platform established

Research, focus and regulatory cunning will be needed if the nutraceutical industry is to tap into the relatively unexplored area of non-alcoholic fatty liver disease (NAFLD), says the consultancy firm behind a new dedicated clinical trial platform.

from NutraIngredients RSS http://ift.tt/1GICI37
via IFTTT

Photo

from Bodybuilding Motivation http://ift.tt/2EtKRn5 via IFTTT

Bodybuilding.com Sponsorship Inquiry Page - Success

Bodybuilding.com Sponsorship Inquiry Page - Success from Bodybuilding.com Articles http://ift.tt/1k3uM9z via IFTTT

Mimicry: Gut bacteria metabolites copy human signalling molecules

New gut-mediated therapies could be on the horizon, according to new research that finds GPCR (G-protein-coupled receptor) ligands, formed by gut bacteria, mimic human signalling molecules. from NutraIngredients RSS http://ift.tt/2wLKjnP via IFTTT

guide supplements bodybuilding

Search This Blog